| 1. |
Dicken BJ, Saunders LD, Jhangri GS, et al. Gastric cancer: establishing predictors of biologic behavior with use of population-based data [J]. Ann Surg Oncol, 2004; 11(6)∶629.
|
| 2. |
彭朝龙， 贺卫东. 1 062例胃癌淋巴结转移相关因素分析 [J]. 医师进修杂志， 2003； 26（1）∶35.
|
| 3. |
Ohta H, Takagi K, Noguchi Y, et al. Endoscopic intramural injection of anti-neoplastic emulsion [J]. Gann， 1984; 75(7)∶641.
|
| 4. |
Oh I, Kang YG, Lee YB, et al. Prolonged release of tegafur from S/O/W multiple emulsion [J]. Drug Dev Ind Pharm， 1998; 24(10)∶889.
|
| 5. |
Atsumi R, Endo K, Kakutani T, et al. Disposition characteristics of mitomycin C-dextran conjugate in normal and tumor-bearing muscles of rabbits [J]. Cancer Res， 1987; 47(21)∶5546.
|
| 6. |
Nomura T, Saikawa A, Morita S, et al. Pharmacokinetic characteristics and therapeutic effects of mitomycin C-dextran conjugates after intratumoural injection [J]. J Control Release， 1998; 52(3)∶239.
|
| 7. |
Matsumoto S, Yamamoto A, Takakura Y, et al. Cellular interaction and in vitro antitumor activity of mitomycin C-dextran conjugate [J]. Cancer Res， 1986; 46(9)∶4463.
|
| 8. |
Akamo Y, Yotsuyanagi T, Mizuno I, et al. Delivery of lymph node-targeted adriamycin by gastric submucosal liposomal injection in rabbits [J]. Jpn J Cancer Res， 1993; 84(2)∶208.
|
| 9. |
Sivakumar P, Panduranga K. Stable polymerized cholesteryl m-ethacrylate liposomes for vincristine delivery [J]. Biomedical Microdevices, 2001; 3(2)∶143.
|
| 10. |
Sivakumar P, Panduranga K. Development of stable polymerized vinyl pyrrolidone-cholesteryl methacrylate liposomes as carriers for drug delivery [J]. Biomed Microdevices， 2002; 4(3)∶197.
|
| 11. |
Pan XQ, Wang H, Lee RJ. Antitumor activity of folate receptor-targeted liposomal doxorubicin in a KB oral carcinoma murine xenograft model [J]. Pharm Res， 2003; 20(3)∶417.
|
| 12. |
Ishida O, Maruyama K, Tanahashi H, et al. Liposomes bearing polyethyleneglycol-coupled transferrin with intracellular targeting property to the solid tumors in vivo [J]. Pharm Res， 2001; 18(7)∶1042.
|
| 13. |
Iinuma H, Maruyama K, Okinaga K, et al. Intracellular targeting therapy of cisplatin-encapsulated transferrin-polyethylene glycol liposome on peritoneal dissemination of gastric cancer [J]. Int J Cancer， 2002; 99(1)∶130.
|
| 14. |
Hosokawa S, Tagawa T, Niki H, et al. Establishment and evaluation of cancer-specific human monoclonal antibody GAH for targeting chemotherapy using immunoliposomes [J]. Hybrid Hybridomics， 2004; 23(2)∶109.
|
| 15. |
Matsumura Y, Gotoh M, Muro K, et al. Phase Ⅰ and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer [J]. Ann Oncol， 2004; 15(3)∶517.
|
| 16. |
Fonseca MJ, Jagtenberg JC, Haisma HJ, et al. Liposome-mediated targeting of enzymes to cancer cells for site-specific activation of prodrugs: comparison with the corresponding antibody-enzyme conjugate [J]. Pharm Res， 2003; 20(3)∶423.
|
| 17. |
黄允宁， 王 炜， 苏 刚， 等. 微粒子活性炭在胃癌淋巴结清扫术中的应用价值 [J]. 中华普通外科杂志， 2002； 17（6）∶354.
|
| 18. |
Nakase Y, Hagiwara A, Kin S, et al. Intratumoral administration of methotrexate bound to activated carbon particles: antitumor effectiveness against human colon carcinoma xenografts and acute toxicity in mice [J]. J Pharmacol Exp Ther， 2004; 311(1)∶382.
|
| 19. |
Ito T, Hagiwara A, Takagi T, et al. Local administration of methotrexate bound to activated carbon particles (MTX-CH) for treating cancers in mice [J]. Anticancer Res， 2003; 23(2B)∶1401.
|
| 20. |
Fujiyama J, Nakase Y, Mochizuki S, et al. Fundamental studies on locally injected methotrexate bound to activated carbon particles (MTX-CH) [J]. Gan To Kagaku Ryoho, 2004; 31(11)∶1844.
|
| 21. |
Hagiwara A, Torii T, Sawai K, et al. Local injection of anti-cancer drugs bound to carbon particles for early gastric cancer——a pilot study [J]. Hepatogastroenterology, 2000; 47(32)∶575.
|
| 22. |
王向昱， 郑志强， 王增寿， 等. 活性炭吸附阿霉素靶向治疗胃癌的临床观察 [J]. 浙江预防医学， 2003; 15(6)∶12.
|
| 23. |
Huang Y, Hagiwara A, Wang W, et al. Local injection of M-CH combined with i.p. hyperthermic hypo-osmolar infusion is an effective therapy in advanced gastric cancer [J]. Anticancer Drugs, 2002; 13(4)∶431.
|
| 24. |
Takahashi T, Hagiwara A, Shimotsuma M, et al. Prophylaxis and treatment of peritoneal carcinomatosis: intraperitoneal chemotherapy with mitomycin C bound to activated carbon particles [J]. World J Surg, 1995; 19(4)∶565.
|
| 25. |
Ohgaki M, Takenaka A, Shiomi A, et al. Intraperitoneal che-motherapy against peritoneal carcinomatosis of gastric cancer with activated carbon particles adsorbing mitomycin C for four patients [J]. Gan To Kagaku Ryoho, 2004; 31(11)∶1858.
|
| 26. |
Rosen HR, Jatzko G, Repse S, et al. Adjuvant intraperitoneal chemotherapy with carbon-adsorbed mitomycin in patients with gastric cancer: results of a randomized multicenter trial of the Austrian Working Group for Surgical Oncology [J]. J Clin Oncol, 1998; 16(8)∶2733.
|
| 27. |
Jansen M, Fass J, Langejurgen E, et al. Effects of intraperitoneal mitomycin C adsorbed on activated carbon on adhesion formation and mesothelial cells in vitro [J]. Eur J Surg, 2000; 166(7)∶572.
|
| 28. |
Jansen M, Jansen PL, Fass J, et al. Influence of intraperitoneal therapy with mitomycin C adsorbed on activated carbon on anastomotic and wound healing in rats [J]. Dig Dis Sci, 2002; 47(9)∶1992.
|
